发明名称 (1S, 4R, 6S, 14S, 18R)-4-FLUORO-1,3-DIHYDRO-ISOINDOLE-2-CARBOXYLIC ACID 14-TERT-BUTOXYCARBONYLAMINO-4-CYCLOPROPANESULFONYLAMINOCARBONYL-2,15-DIOXO-3,16-DIAZATRICYCLONONADEC-7-EN-18-YL ESTER AND ITS USE FOR THE MANUFACTURE OF AN ANTI-HCV INFECTION MEDICAMENT
摘要 The present invention provides compounds of the general formulas I-IX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The present invention further provides treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
申请公布号 IL174704(A) 申请公布日期 2012.12.31
申请号 IL20060174704 申请日期 2006.03.30
申请人 F. HOFFMANN-LA ROCHE LTD;F. HOFFMANN-LA ROCHE LTD.;INTERMUNE, INC.;ARRAY BIOPHARMA, INC;F. HOFFMANN-LA ROCHE LTD;F. HOFFMANN-LA ROCHE INC. 发明人
分类号 A61K;A61K38/00;C07D487/04;C08H1/00 主分类号 A61K
代理机构 代理人
主权项
地址